Eagle Pharmaceuticals
EGRX
#9950
Rank
S$20.91 M
Marketcap
$1.61
Share price
-1.64%
Change (1 day)
-80.92%
Change (1 year)

Earnings for Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): S$47.63 Million

According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings are S$0.25 Billion. In 2022 the company made an earning of S$88.58 Million, an increase over its 2021 earnings that were of -S$3.92 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eagle Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) S$47.63 M-46.23%
2022 S$88.58 M-2361.45%
2021 -S$3.92 Million-111.53%
2020 S$33.95 M2.31%
2019 S$33.19 M-32.89%
2018 S$49.45 M-50.35%
2017 S$99.61 M38.63%
2016 S$71.85 M1966.43%
2015 S$3.47 M-111.46%
2014 -S$30.36 Million282.82%
2013 -S$7.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$23.45 B 48,813.32%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.60 B 11,596.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$18.34 B 38,151.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-S$0.38 Billion-890.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
S$6.19 B 12,825.21%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.05 B 35,460.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$11.27 Billion-23,597.57%๐Ÿ‡บ๐Ÿ‡ธ USA